Skip to main content
European Health and Digital Executive Agency (HaDEA)

12 research projects selected for funding to support the EU Mission on Cancer

Acronym

Title

Coordinating institution

Partners

Call to develop new methods  and technologies for screening and early detection

Total EU funding: €60 million

MammoScreen

 Innovative and safe microwave-based imaging technology to make 

 breast cancer screening more accurate, inclusive and female-friendly

FONDAZIONE TOSCANA LIFE SCIENCES

7 partners: ES, IT (3), PT, UK (2)

ThermoBreast

An innovative non-contact and harmless screening modality set to

 change the course of breast cancer detection and patient monitoring

THERMOMIND LTD

17 partners: BE (2), CH, DE (3), FR, IE, IL (4), IT, LT, NL, SI, US

ONCOSCREEN

A European “shield” against colorectal cancer based on novel, more 

 precise and affordable risk-based screening methods and viable

 policy pathways

EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIS

40 partners: AT (3), BE (4), BG, DE (4), EL (5), ES (2), FR (4), IE (2), IL, IT, LT (3), NL (3), PT (3), RO (3)

PANCAID

PANcreatic CAncer Initial Detection via liquid biopsy

UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF

19 partners: AT, BE, DE (6), ES (2), FR, SE (5), IL (2), UK

SANGUINE

 

 Early detection and screening of hematological malignancies

TEL AVIV UNIVERSITY

11 partners: BE, CZ (2), DE, EL, ES, IL (3), LT (2)

DIOPTRA

 

Early dynamic screening for colorectal cancer via novel protein  

 biomarkers reflecting biological initiation mechanisms

INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS

 

25  partners: AT, BE (3), BG, CY (4), DK (2), EL (6), ES, IT, LT, LU, LV, NL (2), SI 

Call to develop and validate a set of quality of life measures for cancer patients and survivors

Total EU funding: €11 million

EUonQoL

 

Quality of life in Oncology: measuring what matters for cancer patients and survivors in Europe

 

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI

 

27 partners: AT, BE (5), BG, ES, EE, DE, DK, FR (3), IT (7), NL(2), NO, RO, UK (2)

Call to better understand the impact of risk factors and health determinant on the development and progression of cancer

Total EU funding: €54.6 million

MELCAYA

Novel health care strategies for melanoma in children, adolescents and young adults

 

FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA

 

25 partners: AT, DE (4), ES (5), FR (2),  IL, IT (6), NL (2),  PL (2), RO, SE

ELMUMY

Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma

 

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON

 

14 partners: CY, DE (3), EL (4), ES (3), FR (2), IT

GENIAL

Understanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma

 

UNIVERSITE LIBRE DE BRUXELLES

 

12 partners: BE (3), FR (5), PT, IT, DE, SE

LUCIA

Understanding Lung Cancer related risk factors and their Impact

 

TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY

 

19 partners: BE (3), DE (2), ES (8), IL (3), IT, NL, TR

DISCERN

Discovering the causes of three poorly understood cancers in Europe

CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

 

20 partners: BE (2), CZ, EE, ES (3), FR (2), IT (2), NL (3), NO, PL (2), SE, UK (2)

 

More information

How the EU supports research and innovation on cancer

EU Mission on Cancer